Latest Regulatory News

Page 477 of 631
MAC Copper Limited has entered a binding agreement for acquisition by Harmony Gold, offering shareholders a compelling 32% premium and signalling a major consolidation in the copper mining sector.
Maxwell Dee
Maxwell Dee
27 May 2025
REA Group has confirmed it is under investigation by the ACCC concerning its subscription offerings, signaling potential regulatory scrutiny for the property tech giant.
Sophie Babbage
Sophie Babbage
27 May 2025
Bastion Mining has tabled a recommended $0.08 per share cash offer for Xanadu Mines, representing a significant premium and backed unanimously by Xanadu's independent directors and largest shareholder.
Maxwell Dee
Maxwell Dee
27 May 2025
4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.
Ada Torres
Ada Torres
27 May 2025
Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.
Ada Torres
Ada Torres
27 May 2025
TerraCom Limited has reached a significant settlement with ASIC to resolve whistleblower-related civil proceedings, agreeing to pay $8.5 million pending Federal Court approval.
Maxwell Dee
Maxwell Dee
27 May 2025
Beacon Minerals has secured an option agreement to acquire the Wealth of Nations gold tenements near its Jaurdi processing plant, setting the stage for renewed exploration and potential resource growth.
Maxwell Dee
Maxwell Dee
27 May 2025
Piche Resources has received formal environmental approval to begin its maiden drilling campaign at the Cerro Chacon gold-silver project in Argentina, targeting a 14 km mineralised corridor with 57 planned drill holes.
Maxwell Dee
Maxwell Dee
27 May 2025
Wellnex Life Limited’s shares have been suspended from trading on the ASX pending a response to regulatory queries, stirring investor uncertainty.
Ada Torres
Ada Torres
27 May 2025
Prescient Therapeutics has reached a pivotal milestone by dosing the first patient in its Phase 2a clinical trial of PTX-100 for relapsed/refractory Cutaneous T-Cell Lymphoma (CTCL), aiming to evaluate safety and efficacy across multiple international sites.
Ada Torres
Ada Torres
27 May 2025
Coolabah Metals Limited is set to transform into a producing miner with its $15-20 million capital raise, conditional on acquiring Broken Hill Mines Pty Ltd and resuming ASX trading.
Maxwell Dee
Maxwell Dee
27 May 2025
InFocus Group Holdings has secured a $3.25 million contract to develop a cutting-edge white-label iGaming platform for Taiwanese firm TG Solutions, marking a significant expansion into the digital gaming sector.
Sophie Babbage
Sophie Babbage
27 May 2025